PRISMX
NSE: SUNPHARMA Pharma Consensus: NEUTRAL

Sun Pharmaceutical (SUNPHARMA) Technical Intelligence & Key Invalidation Zones

Quantitative Smart Money Order Blocks, institutional consensus, and mathematical reference levels for Sun Pharmaceutical.

Reference EOD Price ₹1,746.4 Session: 2026-10-15

Bull Thesis Invalidation (Support Floor)

₹1,717.54

The institutional bullish setup remains mathematically valid while the asset trades above this price floor.

Bear Thesis Invalidation (Supply Ceiling)

₹1,841.92

The institutional bearish pressure remains dominant while price holds under this supply ceiling.

Multi-Agent Consensus Summary

Signals are split (lean 14%).

Explore Peer Stocks in Pharma

Cipla (CIPLA)Dr. Reddy's Laboratories (DRREDDY)

Frequently Asked Questions (SUNPHARMA)

What is the institutional consensus bias for Sun Pharmaceutical?

Sun Pharmaceutical currently holds a NEUTRAL consensus bias computed by PRISMX multi-agent algorithmic models based on price action and volatility structures.

What are the key support and resistance levels for SUNPHARMA?

The bullish thesis invalidation floor is ₹1,717.54, and the bearish thesis invalidation ceiling is ₹1,841.92.

How does PRISMX compute AI consensus?

PRISMX synthesizes multiple specialized autonomous agents analyzing price structures, volatility bands, Smart Money Order Blocks, and news sentiment, resolving them through a game-theoretic referee.

Quantitative Research Methodology & Author Bio (E-E-A-T)

Architected and validated by Faisal Darjee (Lead AI Architect & Quantitative Researcher, Somaiya School of Basic and Applied Sciences — SSBAS, Somaiya Vidyavihar University). Methodology combines Smart Money Concepts (SMC), gradient boosted trees (XGBoost/LightGBM) with purged time-series validation, and FinBERT sentiment transformers.